Mode
Text Size
Log in / Sign up

Graves orbitopathy

Part of Graves' disease

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Graves orbitopathy

2 trials tracked for Graves orbitopathy: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 694 citations.

2Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 1 Phase 2 1
  1. Phase 3 Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study Completed · 694 cited
  2. Phase 2 A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Graves' disease

Related studies from across the Graves' disease family.

Color Doppler ultrasound differentiates Graves' disease from silent thyroiditis in thyrotoxicosis patients
Diabetes & Endocrinology Cohort
Color Doppler ultrasound differentiates Graves' disease from silent thyroiditis in thyrotoxicosis patients Ultrasound blood flow patterns help distinguish Graves' disease from silent thyroiditis
This single-center prospective observational cohort study of 78 adults with thyrotoxicosis found that color Doppler ultrasound (CDU) with th…
A new study finds that measuring thyroid blood flow with ultrasound can help tell Graves' disease apart from silent thyroiditis, a key diagn…
Case report and review: IVIg and efgartigimod in Guillain-Barré with Graves disease and thyroid cancer
Allergy & Immunology Sys. Review
Case report and review: IVIg and efgartigimod in Guillain-Barré with Graves disease and thyroid cancer Doctors treat a rare relapse of Guillain-Barré syndrome with new immune therapies
This case report and literature review describes a 33-year-old man with Guillain-Barré syndrome, Graves disease, and papillary thyroid carci…
A 33-year-old man with Guillain-Barré syndrome found relief after doctors treated his underlying thyroid cancer and used new immune therapie…
COVID-19 pandemic associated with Hashimoto's increase and Subacute Thyroiditis decrease in Israeli retrospective cohort
Diabetes & Endocrinology Cohort
COVID-19 pandemic associated with Hashimoto's increase and Subacute Thyroiditis decrease in Israeli retrospective cohort Thyroid Disease Rates Shifted During Pandemic
This retrospective cohort study examined 4,765 incident thyroid disease cases among adults in Israel from January 2018 to December 2022.
You felt tired all the time. Maybe your hair started thinning.
Antithyroid drug-induced agranulocytosis patients show distinct T-cell receptor repertoires compared to Graves' disease patients
Allergy & Immunology
Antithyroid drug-induced agranulocytosis patients show distinct T-cell receptor repertoires compared to Graves' disease patients Why Your Thyroid Meds Might Trigger Rare Infections
This observational study compared immune receptor repertoires in patients with antithyroid drug-induced agranulocytosis (TiA) versus those w…
A rare but deadly reaction to thyroid drugs is linked to specific immune cell changes, offering clues to predict who's at risk before infect…